Could the data of home blood pressure monitoring be used to evaluate the risk of subclinical target organ damage in hypertensive patients?

References (1)

1. Her A, Kim YH, Rim S, Kim J, Choi E, Min P, et al. Home blood pressure is the predictor of subclinical target organ damage like ambulatory blood pressure monitoring in untreated hypertensive patients. Anatol J Cardiol 2014; 14: 711-8. [CrossRef] 2. Kiselev AR, Gridnev VI, Shvartz VA, Posnenkova OM, Dovgalevsky PY. Active ambulatory care management supported by short message services and mobile phone technology in patients with arterial hypertension. J Am Soc Hypertens 2012; 6: 346-55. [CrossRef] 3. Boytsov SA, Yakushin SS, Martsevich SY, Lukyanov MM, Nikulina NN, Zagrebelny AV, et al. Outpatient register of cardiovascular diseases in the Ryazan region (RECVASA): principal tasks, experience of development and first results. Rational Pharmacother Card 2013; 9: 4-14. 4. Parati G, Stergiou GS, Asmar R, Bilo G, Leeuw P, Imai Y, et al. European society of hypertension practice guidelines for home blood pressure moni- toring. J Human Hyperten 2010; 24: 779-85. [CrossRef]